News in the Life Sciences Industry

VICTORIA, BC, Nov. 23, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that it has selected more than ten, unique monoclonal antibodies... Read more ››

Onsite Testing Will Keep Players and Staff Safe Ahead of World Junior Championship in Edmonton

CAMH population survey reveals pre-pandemic picture of youth mental health

As part of the 2020 National Kinesiology Week, kinesiologists want to help Canadians develop strategies to move better and live better for their mental and physical health.

TORONTO, Nov. 20, 2020 /CNW/ - RNAO thanks the government for listening to the voices of nurses and imposing a 28-day partial lockdown for Toronto and Peel region. However, much more was asked of government at the association's media conference Nov. 13.

- Bamlanivimab emerged from collaboration between Lilly and Vancouver-based AbCellera

MONTREAL, Nov. 20, 2020 /CNW Telbec/ - The founder of Groupe Persavita Inc, Mahmood Piraee (PharmD, PhD), also a community pharmacist in Montreal, believes that his experimental natural health product has the potential to help Covid-19 patients in many ways. The company is gearing up to test... Read more ››

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, BC, Nov. 19, 2020 /CNW/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE American: CRHM), announces that it has received approval from the Toronto Stock Exchange ("TSX") of its Notice of Intention to renew its existing Normal Course Issuer Bid (the... Read more ››

TORONTO, Nov. 19, 2020 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, announces that in connection with its previously announced normal course issuer bid ("NCIB") to purchase up... Read more ››

QUEBEC CITY, Nov. 19, 2020 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today reported its results for the fourth quarter and fiscal year 2020 ended August 31, 2020.

Research sponsored by Dialogue, conducted by Environics Research reveals Canadians' current perceptions about the growing telemedicine industry